Related content

Fc Engineering to Improve the Function of Therapeutic Antibodies

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 15, 2016-12 ,pp. : 1298-1314

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Fc Receptors as a Therapeutic Target

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 1, 2009-03 ,pp. : 80-86

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Fc-related Antibody Engineering)

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 15, 2016-12 ,pp. : 1296-1297

Bentham Science Publishers

Access to resources Recommend Favorite

Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 6, 2008-12 ,pp. : 482-501

Bentham Science Publishers

Access to resources Recommend Favorite

Human and Non-Human Primate Intestinal FcRn Expression and Immunoglobulin G Transcytosis

By Hornby Pamela   Cooper Philip   Kliwinski Connie   Ragwan Edwin   Mabus John   Harman Benjamin   Thompson Suzanne   Kauffman Amanda   Yan Zhengyin   Tam Susan   Dorai Haimanti   Powers Gordon   Giles-Komar Jill  

Pharmaceutical Research, Vol. 31, Iss. 4, 2014-04 ,pp. : 908-922

Springer Publishing Company

Access to resources Recommend Favorite